App-Quantinova.ai

Lack of the Alpha-11 Integrin in the Heart is Associated With Progressive Diastolic Dysfunction, Myofibrillar Disarray and Impaired Cardiomyocyte Growth

Ilana Talior-Volodarsky - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Diastolic dysfunction

Dermatan sulfate

Paradoxical Association of LDL Measures With the Risk of Incident Atrial Fibrillation

Akintunde O Akinkuolie - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Hemostatic Solution

Correlation of Cardiac MRI Findings and Endomyocardial Biopsy Results in Patients Undergoing Screening for Heart Transplant Rejection

Kelvin Chow - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic antibody mediated rejection

N/A

Pro-angiogenic Dual Gene Therapy in Chronic Diabetic Hindlimb Ischemia with Ultrasound Mediated Delivery of miR-126 and VEGF Plasmid DNA

Pratiek N Matkar - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease: Results From TRACER

Pierluigi Tricoci - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Peripheral artery disease

Vorapaxar

Combining Echo Doppler and CT Derived LVOT Measurements Improve Accuracy of Continuity Equation Based Aortic Valve Area Determination

Asim Cheema - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Obstructive Sleep Apnea Independently Mediates Cardio-Metabolic Risk in Obese Adolescents

Brian W McCrindle - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Sleep apnoea

N/A

Three-Dimensional Echocardiography Identify Mechanisms of Early Post Operative Valve Failure in Pediatric and Congenital Heart Disease

Timothy Colen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Atrioventricular septal defect

N/A

Statin Use After an Acute In-Hospital Myocardial Infarction Among Medicare Beneficiaries

Monika Safford - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Skeletal Muscle Proteomic Signature in Pulmonary Arterial Hypertension

Francois Potus - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary arterial hypertension

N/A

[18F]-fluorodeoxyglucose is a Stronger Correlate of Intraplaque Inflammatory Burden in Human Carotid Plaque Than C-Reactive Protein: A Sub-Study of the Canadian Atherosclerosis Imaging Network (CAIN)

J David Spence - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Impact of Pulse Pressure on the Progression of Aortic Valve Calcification in Patients with Aortic Stenosis

Romain Capoulade - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

Angiotensin II

Can Salvage Takedown of Cavopulmonary Connection Act as a Bridge to Subsequent Palliation?

Devin Chetan - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Superior Vena Cava Syndrome

N/A

Coronary Flow Velocity Reserve and Aortic Regurgitation Index Before and After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis

Pallav Garg - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

Adenosine

Short- and Long-Term Outcomes of Patients With Type A Acute Aortic Dissection and Cardiogenic Shock: Contemporary Results From the International Registry of Acute Aortic Dissection (IRAD)

Reed E Pyeritz - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

N/A

Maladaptive Aortic Properties after the Norwood Procedure: an Angiographic Analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial

Christoph P Hornik - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

Reduced ?-catenin Expression in Mouse Cardiomyocytes Increases Matrix Metalloproteinase Activation and Apoptosis, Producing Greater Post-Infarction Ventricular Dysfunction

Anton Mihic - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

TIMP-3 secretion inducer

Prognostic Value of Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Patients With Heart Failure: Data From CORONA

Stale Nymo - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

Rosuvastatin

Under Use of Statins and LDL-C Control Among People With a Framingham 10-Year Coronary Heart Disease Risk > 20%

Emily Levitan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

Tdag51 Deficiency Protects Against Aortic Vascular Calcification by Attenuating Smooth Muscle Cell Death and Osteoblastic Trans-Differentiation

Alistair Ingram - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Angiology

Left ventricular hypertrophy

Alkaline phosphatase

Filters

28841 Abstracts